Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-146.46 Insider Own0.07% Shs Outstand1.96M Perf Week0.85%
Market Cap4.65M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.96M Perf Month-25.35%
Income-32.70M PEG- EPS next Q- Inst Own1.36% Short Float0.99% Perf Quarter-41.34%
Sales0.65M P/S7.15 EPS this Y- Inst Trans- Short Ratio0.05 Perf Half Y-71.45%
Book/sh12.17 P/B0.19 EPS next Y- ROA-117.08% Short Interest0.02M Perf Year-91.80%
Cash/sh0.05 P/C46.45 EPS next 5Y- ROE-304.58% 52W Range2.14 - 68.08 Perf YTD-64.25%
Dividend Est.- P/FCF- EPS past 5Y45.26% ROI-191.25% 52W High-96.52% Beta1.11
Dividend TTM- Quick Ratio0.24 Sales past 5Y151.61% Gross Margin-101.41% 52W Low10.75% ATR (14)0.30
Dividend Ex-Date- Current Ratio0.27 EPS Y/Y TTM82.03% Oper. Margin-4039.58% RSI (14)35.19 Volatility9.07% 12.17%
Employees47 Debt/Eq1.13 Sales Y/Y TTM-30.90% Profit Margin-5068.49% Recom1.00 Target Price3.70
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q88.86% Payout- Rel Volume0.08 Prev Close2.27
Sales Surprise- EPS Surprise- Sales Q/Q-56.20% Earnings- Avg Volume370.96K Price2.37
SMA20-18.17% SMA50-27.95% SMA200-72.60% Trades Volume28,039 Change4.41%
Apr-02-24 08:30AM
Mar-27-24 08:36AM
Mar-20-24 08:54AM
Mar-07-24 07:54AM
08:00AM Loading…
Feb-01-24 08:00AM
Jan-30-24 08:30AM
Jan-08-24 08:30AM
Jan-05-24 08:30AM
Jan-02-24 08:30AM
Dec-29-23 05:07PM
Dec-12-23 11:20AM
Nov-30-23 07:39AM
Oct-06-23 08:00AM
08:00AM Loading…
Oct-05-23 08:00AM
Sep-21-23 09:35AM
Sep-08-23 07:05AM
Sep-06-23 04:30PM
Aug-31-23 07:00PM
Aug-18-23 07:02AM
Aug-17-23 04:12PM
Jun-20-23 07:49AM
May-19-23 06:10AM
May-05-23 07:05AM
Apr-24-23 04:15PM
Apr-20-23 01:35PM
Apr-17-23 07:00AM
Mar-08-23 08:30AM
08:30AM Loading…
Mar-03-23 08:30AM
Feb-14-23 08:30AM
Jan-12-23 08:46AM
Jan-03-23 09:00AM
Dec-05-22 08:52AM
Oct-21-22 09:00AM
Oct-12-22 09:00AM
Oct-07-22 09:00AM
Sep-30-22 08:34AM
Sep-29-22 09:00AM
Sep-27-22 09:00AM
Sep-20-22 04:09PM
Sep-16-22 09:20AM
Sep-13-22 04:15PM
Aug-02-22 08:17AM
Jul-08-22 08:30AM
Jun-14-22 02:00PM
Apr-14-22 09:00AM
Apr-05-22 08:30AM
Mar-23-22 08:30AM
Jan-18-22 08:30AM
Jan-14-22 09:00AM
Jan-12-22 09:00AM
Dec-31-21 06:00PM
Dec-30-21 04:58PM
Dec-29-21 09:45PM
Dec-28-21 12:33PM
Dec-13-21 08:44AM
Dec-02-21 09:20AM
Dec-01-21 09:36AM
Nov-30-21 07:14PM
Nov-22-21 09:00AM
Nov-12-21 12:00PM
Nov-03-21 09:00AM
Oct-20-21 05:31PM
Oct-18-21 07:38AM
Oct-07-21 09:15AM
Oct-05-21 12:41PM
Sep-27-21 08:45AM
Sep-09-21 08:26AM
Sep-07-21 09:15AM
Aug-26-21 09:15AM
Aug-25-21 09:16AM
Aug-11-21 08:00AM
Aug-04-21 08:00AM
Jul-12-21 08:00AM
Jul-07-21 08:00AM
Jun-18-21 08:00AM
Jun-15-21 08:00AM
May-06-21 08:00AM
May-03-21 02:15PM
Apr-13-21 08:31AM
Apr-06-21 08:31AM
Apr-01-21 08:31AM
Mar-24-21 08:59AM
Mar-22-21 08:31AM
Mar-04-21 08:30AM
Jan-29-21 09:24AM
Jan-26-21 08:54AM
Jan-21-21 08:00AM
Dec-14-20 08:00AM
Dec-08-20 08:00AM
Nov-30-20 08:30AM
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BNP PARIBAS SECURITIES CORPReduced under 10% ownerSep 07 '23Sale33.2320,800691,14022,342Sep 07 05:41 PM